Form 4: Edwards Lifesciences Director Leslie C. Davis Reports Acquisition of Restricted Stock Units

Director Leslie C. Davis reports acquisition of 3,528 restricted stock units in Edwards Lifesciences Corp.

Summary

• Leslie C. Davis, a director of Edwards Lifesciences Corp, reported acquiring 3,528 shares of common stock on May 9, 2025.
• These shares were in the form of restricted stock units granted under the company's 2020 Nonemployee Directors Stock Incentive Program.
• The restricted stock units were granted at a price of $0.0000.
• These units are scheduled to vest 100% after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
• Following the transaction, Davis directly owns 6,583 shares of Edwards Lifesciences Corp.
• The report reflects changes in beneficial ownership only and does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard transaction that aligns director interests with shareholders through stock ownership.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the transactions of company directors and officers.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning the director's interests with the company's long-term performance.

Key Dates

Keywords

Edwards Lifesciences, Director, Leslie C. Davis, Restricted Stock Units, Beneficial Ownership, Form 4, Stock Incentive Program